Previous Next

2024-04-02

Metabolites of the tricarboxylic acid pathway in the progression of chronic renal failure

Urology-nephrology

In this study, researchers evaluated the association between metabolites of the tricarboxylic acid pathway and the risk of progression to chronic kidney disease in patients with type 2 diabetes. Urinary lactate, pyruvate, citrate, alpha-ketoglutarate, succinate, fumarate and malate were measured by mass spectrometry. Over a median follow-up of 9.2 years, urinary lactate, fumarate and malate were associated with an increased risk of kidney damage, while citrate was associated with a low risk of kidney problems, after adjusting for cardio-renal risk factors. 


Source(s) :
Jian-Jun Liu et al. Urine tricarboxylic acid cycle metabolites and risk of end stage kidney disease in patients with type 2 diabetes. J Clin Endocrinol Metab. 2024 Mar 28:dgae199. ;

Last press reviews


Curcumin in prostate cancer: a promising therapy supported by nanotechnology

By Carolina Lima | Published on November 4, 2025 | 3 min read<br>

Plant-based diets and disease progression in men with prostate cancer

By Lila Rouland | Published on November 4, 2025 | 3 min read<br><br>...

Omega-3 fatty acids: a nutritional lever against prostate cancer

By Lila Rouland | Published on November 3, 2025 | 3 min read<br><br>...